Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life

Pamela L. Wolters, Katherine M. Burns, Staci Martin, Andrea Baldwin, Eva Dombi, Mary Anne Toledo-Tamula, William N. Dudley, Andrea Gillespie, Brigitte C. Widemann

Research output: Contribution to journalArticle

Abstract

The physical manifestations of neurofibromatosis type 1 (NF1) can cause chronic pain. This study investigated the impact of pain in youth with NF1 and plexiform neurofibromas (PNs) and its relationship to disease factors, social-emotional functioning, and quality of life (QOL) within a biopsychosocial framework. Caregivers of 59 children and adolescents with NF1 and PNs (6-18 years), and 41 of these youth (10-18 years), completed questionnaires assessing social-emotional functioning and QOL, including an item on pain interference. Measures of disease severity included total PN volume by percent body weight and number of disease complications. Both caregiver (73%) and self-report (59%) ratings indicated that pain interferes with the child's daily functioning despite 33% taking pain medication. Based on caregivers' behavior ratings, more symptoms of anxiety and larger tumor volumes predicted greater pain interference, while greater pain interference, worse depressive symptoms, and more disease complications predicted poorer QOL. As rated by adolescents, more symptoms of anxiety predicted greater pain interference, while greater pain interference and social stress predicted poorer QOL. Further, social-emotional problems mediate the relationship between pain interference and QOL. Thus, pain interferes with daily functioning in the majority of youth with NF1 and PNs even when using pain medication. The impact of pain interference, disease severity, and particularly social-emotional problems on QOL highlights the interaction between physical and psychological states in NF1. Future research and treatment of pain in this population should utilize a biopsychosocial approach and involve multidisciplinary therapies including psychological interventions that target social-emotional functioning.

Original languageEnglish (US)
Pages (from-to)2103-2113
Number of pages11
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number9
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Plexiform Neurofibroma
Neurofibromatosis 1
Quality of Life
Pain
Caregivers
Social Problems
Anxiety
Psychology
Tumor Burden

Keywords

  • Children
  • Neurofibromatosis type 1
  • Pain
  • Plexiform neurofibromas
  • Quality of life

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. / Wolters, Pamela L.; Burns, Katherine M.; Martin, Staci; Baldwin, Andrea; Dombi, Eva; Toledo-Tamula, Mary Anne; Dudley, William N.; Gillespie, Andrea; Widemann, Brigitte C.

In: American Journal of Medical Genetics, Part A, Vol. 167, No. 9, 01.09.2015, p. 2103-2113.

Research output: Contribution to journalArticle

Wolters, Pamela L. ; Burns, Katherine M. ; Martin, Staci ; Baldwin, Andrea ; Dombi, Eva ; Toledo-Tamula, Mary Anne ; Dudley, William N. ; Gillespie, Andrea ; Widemann, Brigitte C. / Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. In: American Journal of Medical Genetics, Part A. 2015 ; Vol. 167, No. 9. pp. 2103-2113.
@article{6172b0a5da284dbbae0d8018a4134c8e,
title = "Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life",
abstract = "The physical manifestations of neurofibromatosis type 1 (NF1) can cause chronic pain. This study investigated the impact of pain in youth with NF1 and plexiform neurofibromas (PNs) and its relationship to disease factors, social-emotional functioning, and quality of life (QOL) within a biopsychosocial framework. Caregivers of 59 children and adolescents with NF1 and PNs (6-18 years), and 41 of these youth (10-18 years), completed questionnaires assessing social-emotional functioning and QOL, including an item on pain interference. Measures of disease severity included total PN volume by percent body weight and number of disease complications. Both caregiver (73{\%}) and self-report (59{\%}) ratings indicated that pain interferes with the child's daily functioning despite 33{\%} taking pain medication. Based on caregivers' behavior ratings, more symptoms of anxiety and larger tumor volumes predicted greater pain interference, while greater pain interference, worse depressive symptoms, and more disease complications predicted poorer QOL. As rated by adolescents, more symptoms of anxiety predicted greater pain interference, while greater pain interference and social stress predicted poorer QOL. Further, social-emotional problems mediate the relationship between pain interference and QOL. Thus, pain interferes with daily functioning in the majority of youth with NF1 and PNs even when using pain medication. The impact of pain interference, disease severity, and particularly social-emotional problems on QOL highlights the interaction between physical and psychological states in NF1. Future research and treatment of pain in this population should utilize a biopsychosocial approach and involve multidisciplinary therapies including psychological interventions that target social-emotional functioning.",
keywords = "Children, Neurofibromatosis type 1, Pain, Plexiform neurofibromas, Quality of life",
author = "Wolters, {Pamela L.} and Burns, {Katherine M.} and Staci Martin and Andrea Baldwin and Eva Dombi and Toledo-Tamula, {Mary Anne} and Dudley, {William N.} and Andrea Gillespie and Widemann, {Brigitte C.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/ajmg.a.37123",
language = "English (US)",
volume = "167",
pages = "2103--2113",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life

AU - Wolters, Pamela L.

AU - Burns, Katherine M.

AU - Martin, Staci

AU - Baldwin, Andrea

AU - Dombi, Eva

AU - Toledo-Tamula, Mary Anne

AU - Dudley, William N.

AU - Gillespie, Andrea

AU - Widemann, Brigitte C.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - The physical manifestations of neurofibromatosis type 1 (NF1) can cause chronic pain. This study investigated the impact of pain in youth with NF1 and plexiform neurofibromas (PNs) and its relationship to disease factors, social-emotional functioning, and quality of life (QOL) within a biopsychosocial framework. Caregivers of 59 children and adolescents with NF1 and PNs (6-18 years), and 41 of these youth (10-18 years), completed questionnaires assessing social-emotional functioning and QOL, including an item on pain interference. Measures of disease severity included total PN volume by percent body weight and number of disease complications. Both caregiver (73%) and self-report (59%) ratings indicated that pain interferes with the child's daily functioning despite 33% taking pain medication. Based on caregivers' behavior ratings, more symptoms of anxiety and larger tumor volumes predicted greater pain interference, while greater pain interference, worse depressive symptoms, and more disease complications predicted poorer QOL. As rated by adolescents, more symptoms of anxiety predicted greater pain interference, while greater pain interference and social stress predicted poorer QOL. Further, social-emotional problems mediate the relationship between pain interference and QOL. Thus, pain interferes with daily functioning in the majority of youth with NF1 and PNs even when using pain medication. The impact of pain interference, disease severity, and particularly social-emotional problems on QOL highlights the interaction between physical and psychological states in NF1. Future research and treatment of pain in this population should utilize a biopsychosocial approach and involve multidisciplinary therapies including psychological interventions that target social-emotional functioning.

AB - The physical manifestations of neurofibromatosis type 1 (NF1) can cause chronic pain. This study investigated the impact of pain in youth with NF1 and plexiform neurofibromas (PNs) and its relationship to disease factors, social-emotional functioning, and quality of life (QOL) within a biopsychosocial framework. Caregivers of 59 children and adolescents with NF1 and PNs (6-18 years), and 41 of these youth (10-18 years), completed questionnaires assessing social-emotional functioning and QOL, including an item on pain interference. Measures of disease severity included total PN volume by percent body weight and number of disease complications. Both caregiver (73%) and self-report (59%) ratings indicated that pain interferes with the child's daily functioning despite 33% taking pain medication. Based on caregivers' behavior ratings, more symptoms of anxiety and larger tumor volumes predicted greater pain interference, while greater pain interference, worse depressive symptoms, and more disease complications predicted poorer QOL. As rated by adolescents, more symptoms of anxiety predicted greater pain interference, while greater pain interference and social stress predicted poorer QOL. Further, social-emotional problems mediate the relationship between pain interference and QOL. Thus, pain interferes with daily functioning in the majority of youth with NF1 and PNs even when using pain medication. The impact of pain interference, disease severity, and particularly social-emotional problems on QOL highlights the interaction between physical and psychological states in NF1. Future research and treatment of pain in this population should utilize a biopsychosocial approach and involve multidisciplinary therapies including psychological interventions that target social-emotional functioning.

KW - Children

KW - Neurofibromatosis type 1

KW - Pain

KW - Plexiform neurofibromas

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84939470514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939470514&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.37123

DO - 10.1002/ajmg.a.37123

M3 - Article

VL - 167

SP - 2103

EP - 2113

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -